MarketCap
Xenon Pharmaceuticals XENE
€ 32.07
1.06%
Facebook
X
Telegram
Land |
 Kanada |
IPO-Jahr |
2014 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
79.3 M |
Marktkapitalisierung |
$ 2.83 B |
EBITDA (LTM) |
$ -371 M |
P/E (LTM) |
-13.704128 |
P/S (LTM) |
631.388216 |
EPS (LTM) |
-4.36 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market |  USA |
 |
Atossa Therapeutics
ATOS
|
$ 2.45 | -5.91 % | $ 21.1 M | Nasdaq Capital Market | USA |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 16.09 | 2.78 % | $ 1.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Arcus Biosciences
RCUS
|
$ 17.7 | -4.53 % | $ 1.9 B | NYSE,SPB | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.43 | 0.57 % | $ 5.3 B | Nasdaq Global Market |  Israel |
 |
Regeneron Pharmaceuticals
REGN
|
$ 808.08 | 0.38 % | $ 84.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Replimune Group
REPL
|
$ 12.48 | 8.9 % | $ 1.16 B | Nasdaq Global Select Market | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
Rafael Holdings
RFL
|
$ 1.18 | -9.92 % | $ 34.7 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 6.58 | -1.5 % | $ 339 M | Nasdaq Global Select Market,SPB | USA |
 |
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | USA |
 |
Rigel Pharmaceuticals
RIGL
|
$ 49.95 | 3.78 % | $ 898 M | Nasdaq Global Select Market | USA |
 |
Compugen Ltd.
CGEN
|
$ 1.89 | -2.84 % | $ 177 M | Nasdaq Global Market,SPB | Israel |
 |
Relay Therapeutics
RLAY
|
$ 18.16 | -0.11 % | $ 3.12 B | Nasdaq Global Market | USA |
 |
Coherus BioSciences
CHRS
|
$ 1.0 | -0.5 % | $ 117 M | Nasdaq Global Market | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
Royalty Pharma plc
RPRX
|
$ 64.76 | 1.4 % | $ 27.8 B | Nasdaq Global Select Market | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 89.56 | 0.32 % | $ 5.82 B | Nasdaq Global Market,SPB | USA |
 |
Rezolute
RZLT
|
$ 3.82 | -1.04 % | $ 397 M | Nasdaq Capital Market | USA |
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.43 | -16.94 % | $ 2.81 M | Nasdaq Global Select Market,SPB | USA |
 |
Sana Biotechnology
SANA
|
$ 2.36 | 1.29 % | $ 598 M | Nasdaq Global Select Market | USA |
 |
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market | USA |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.07 | -4.05 % | $ 49.6 M | Nasdaq Capital Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
Seer
SEER
|
$ 1.93 | -2.03 % | $ 107 M | Nasdaq Global Select Market | USA |
 |
CohBar
CWBR
|
- | -15.44 % | $ 2.2 M | Nasdaq Capital Market | USA |
 |
SIGA Technologies
SIGA
|
$ 3.16 | 1.12 % | $ 226 M | Nasdaq Global Select Market | USA |
 |
NeuBase Therapeutics
NBSE
|
- | -1.56 % | $ 12.3 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 6.61 | 3.04 % | $ 575 M | Nasdaq Global Select Market | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 70.54 | 1.57 % | $ 197 M | Nasdaq Global Select Market | Israel |
|
Silence Therapeutics plc
SLN
|
$ 19.77 | 0.48 % | $ 2.8 B | Nasdaq Global Select Market |  Britain |
 |
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Scopus BioPharma
SCPS
|
- | -48.37 % | $ 3.71 M | Nasdaq Global Select Market | USA |
 |
Syndax Pharmaceuticals
SNDX
|
$ 13.21 | -1.42 % | $ 1.14 B | Nasdaq Global Select Market | USA |
 |
Soligenix
SNGX
|
$ 0.35 | -4.08 % | $ 1.82 M | Nasdaq Capital Market | USA |
 |
scPharmaceuticals
SCPH
|
- | - | $ 218 M | Nasdaq Global Select Market | USA |
 |
Spruce Biosciences
SPRB
|
$ 43.74 | -3.12 % | $ 33.5 M | Nasdaq Global Select Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.07 | -4.05 % | $ 59.9 M | Nasdaq Global Select Market | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 17.99 | 0.73 % | $ 1.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Sutro Biopharma
STRO
|
$ 8.79 | -5.79 % | $ 74.7 M | Nasdaq Global Select Market | USA |
 |
Shattuck Labs
STTK
|
$ 5.55 | 1.09 % | $ 386 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 40.79 | 0.22 % | $ 2.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Savara
SVRA
|
$ 4.53 | 7.23 % | $ 1.01 B | Nasdaq Global Select Market | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 3.49 | -14.88 % | $ 2.37 M | Nasdaq Global Select Market |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 20.45 | 1.01 % | $ 32.3 B | NYSE |  Japan |